PYC pyc therapeutics limited

Ann: Fourth Drug Program Progressing to Human Trials, page-8

  1. 2,521 Posts.
    lightbulb Created with Sketch. 1644
    I am of the view that the company must do a licence deal on ‘something’ over the next 12 months to provide the company with sufficient cash to take one of the blockbusters to the finish line … without another domestic backed capital raise.

    The only exception to that would be if the share price was much higher and they did a targeted ‘cross over’ equity funding deal as the precursor to a NASDAQ listing in 12 months.

    we don’t want to be sitting here in 12 months worried about another discounted (highly dilutive) fund raising … and who knows what global equity markets are going to look like with Trump in the drivers seat!
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$1.36
Change
0.000(0.00%)
Mkt cap ! $793.2M
Open High Low Value Volume
$1.37 $1.44 $1.34 $1.022M 752.3K

Buyers (Bids)

No. Vol. Price($)
1 692 $1.30
 

Sellers (Offers)

Price($) Vol. No.
$1.36 5666 1
View Market Depth
Last trade - 16.10pm 16/07/2025 (20 minute delay) ?
PYC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.